Therefore, the observed reduced activity of MMP-2 in M10/PDX cells suggests that inhibiting the PCs could alter the invasive and metastatic phenotypes of melanoma cells induced by altered p53, CDKN2A genes and/or probably other genes such as Ras (Fig. 7). This evidence concerns the gene MMP2 and melanoma.